z-logo
open-access-imgOpen Access
Cytokine Production by a New Undifferentiated Human Thyroid Carcinoma Cell Line, FB-11
Author(s) -
Lisa B. Fiore,
Luca Emanuele Pollina,
Gabriella Fontanini,
Rosario Casalone,
Maria Teresa Berlingieri,
Riccardo Giannini,
Furio Pacini,
Paolo Miccoli,
Antonio Toniolo,
Alfredo Fusco,
Fulvio Basolo
Publication year - 1997
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jcem.82.12.4444
Subject(s) - thyroglobulin , thyroid peroxidase , thyroid , cell culture , biology , cytokine , cancer research , thyroid carcinoma , thyroid cancer , medicine , endocrinology , microbiology and biotechnology , immunology , genetics
A human anaplastic thyroid cancer cell line FB-1, derived from a 68-yr-old woman who underwent surgery for anaplastic thyroid cancer, has been established. The spindlelike cells have been proliferating stably for more than 2 yr. Karyotype analysis shows many abnormalities and many marker chromosomes have been observed. Heterotransplant of FB-1 cells into severe combined immunodeficient mice has resulted in rapidly growing tumors classified as anaplastic carcinomas, although 50% have shown areas with a trabecular pattern. FB-1 cells failed to express messenger RNA for thyroglobulin; TSH-receptor; thyroperoxidase, and placental angiogenic growth factor. Conversely, PAX8 and thyroid transcription factor 1, whose expression is thyroid specific, was kept in an FB-1 cell line at a level comparable with that observed in normal thyroid tissue. In addition, the present cell line expressed high levels of messenger RNA for high-mobility group proteins (Y) and -C. The in vitro study revealed that FB-1 cells are able to produce high levels of interleukin (IL)-8 and medium amount of IL-6, whereas no release of IL-1-α, IL-1-β, and IL-4 was observed. No modulation of cell proliferation and DNA synthesis in FB-1 cells has been observed after the addition of exogenous IL-6.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom